Carcinoma in situ of other and unspecified genital organs
Chapter 2:Neoplasms
ICD-10 D07 is a billable code used to indicate a diagnosis of carcinoma in situ of other and unspecified genital organs.
Carcinoma in situ (CIS) of the genital organs refers to a localized cancerous condition where abnormal cells are present but have not invaded surrounding tissues. This diagnosis is critical as it indicates a pre-invasive stage of cancer, which can potentially progress to invasive cancer if left untreated. The term 'other and unspecified genital organs' encompasses various sites within the genital region, including the vulva, vagina, cervix, and other less common sites. Surveillance protocols for patients diagnosed with D07 typically involve regular gynecological examinations, Pap smears, and possibly colposcopy to monitor for any changes in the cellular structure. The risk of progression to invasive cancer varies depending on the specific site of the carcinoma, the patient's age, and other risk factors such as HPV infection. Early detection and intervention are crucial in managing this condition effectively, as timely treatment can prevent the development of invasive cancer.
Detailed documentation of the diagnosis, site, treatment plan, and follow-up care.
Routine screenings, abnormal Pap results, and follow-up after treatment.
Ensure that all findings from examinations and biopsies are clearly documented to support the diagnosis.
Comprehensive treatment plans, including surgical, medical, and radiation therapy details.
Management of patients with a history of carcinoma in situ and monitoring for progression.
Documentation should include any multidisciplinary team discussions and decisions regarding treatment.
Used for routine screening in patients at risk for carcinoma in situ.
Document the reason for the Pap smear and any abnormal findings.
Gynecologists should ensure follow-up protocols are in place for abnormal results.
Carcinoma in situ refers to abnormal cells that have not invaded surrounding tissues, while invasive carcinoma has spread beyond the original site into nearby tissues.
